Data / Drug companies / Paliperidone
Paliperidone: 19 companies and 69 products in the FDA NDC directory
Paliperidone is listed in the FDA National Drug Code Directory by 19 companies, with 69 products in commercial distribution. 65 of the products (94.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet, film coated, extended release, and the newest product started marketing on December 18, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 19
- Products
- 69
- Generic (ANDA) products
- 65 (94.2%)
- Application numbers
- 10
- Routes
- Oral
- Brand names
- Invega
- openFDA record search
- api.fda.gov
Companies that list paliperidone
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Ajanta Pharma USA Inc. | 4 | tablet, extended release | Generic drugs (ANDA) | June 26, 2024 |
| Alembic Pharmaceuticals Inc. | 4 | tablet, extended release | Generic drugs (ANDA) | September 30, 2024 |
| Alembic Pharmaceuticals Limited | 4 | tablet, extended release | Generic drugs (ANDA) | September 30, 2024 |
| Amneal Pharmaceuticals LLC | 4 | tablet, extended release | Generic drugs (ANDA) | September 24, 2019 |
| Ani Pharmaceuticals, Inc. | 4 | tablet, extended release | Generic drugs (ANDA) | November 27, 2019 |
| AvKARE | 4 | tablet, extended release | Generic drugs (ANDA) | July 28, 2023 |
| Bryant Ranch Prepack | 4 | tablet, extended release | Generic drugs (ANDA) | December 9, 2025 |
| Camber Pharmaceuticals, Inc. | 4 | tablet, extended release | Generic drugs (ANDA) | August 23, 2023 |
| Cranbury Pharmaceuticals, LLC | 4 | tablet, extended release | Generic drugs (ANDA) | October 29, 2020 |
| Eskayef Pharmaceuticals Limited | 4 | tablet, extended release | Generic drugs (ANDA) | October 2, 2025 |
| Janssen Pharmaceuticals, Inc. | 4 | tablet, extended release | New drug applications (NDA) | September 10, 2009 |
| NorthStar Rx LLC | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | October 15, 2018 |
| Sun Pharmaceutical Industries, Inc. | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | August 1, 2018 |
| Westminster Pharmaceuticals, LLC | 4 | tablet, extended release | Generic drugs (ANDA) | December 9, 2025 |
| Archis Pharma LLC | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | April 27, 2022 |
| Major Pharmaceuticals | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | August 1, 2018 |
| Remedyrepack Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | January 27, 2025 |
| American Health Packaging | 2 | tablet, extended release | Generic drugs (ANDA) | January 15, 2020 |
| Coupler LLC | 2 | tablet, extended release | Generic drugs (ANDA) | December 18, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 55 | 79.7% |
| Tablet, film coated, extended release | 14 | 20.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 65 | 94.2% |
| New drug applications (NDA) | 4 | 5.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Atypical Antipsychotic | 69 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.